ARID1A nuclear expression was inversely related to tumor size (p = 0.006), pathology grade (MCp = 0.046), and post-microwave ablation tumor recurrence (FEp = 0.041) among patients with BCLC stages 0/A eligible for ablation [81]. The gene discussed is ARID1A; the disease is neoplasm.